Evidence map›Paper›PMID 34048452›Full record

ArticlePloS one2021

Clinical efficacy of Curcuvet and Boswellic acid combined with conventional nutraceutical product: An aid to canine osteoarthritis.

Chiara Caterino, Federica Aragosa, Giovanni Della Valle, Dario Costanza, Francesco Lamagna, Alfonso Piscitelli, Annalisa Nieddu, Gerardo Fatone

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chiara CaterinoDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.
Federica AragosaDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.
Giovanni Della ValleDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.ORCID 0000-0002-5424-6335
Dario CostanzaInterdepartmental Center of Veterinary Radiology, University of Naples "Federico II", Naples, Italy.ORCID 0000-0001-7310-0246
Francesco LamagnaDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.
Alfonso PiscitelliDepartment of Agricultural Sciences, University of Naples "Federico II", Portici, Italy.
Annalisa NiedduVeterinary Division, Aurora Biofarma, Milano, Italy.
Gerardo FatoneDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.
University of Naples Federico II · ITFederico II University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOsteoarthritis is a progressive degenerative joint disease which is high prevalent in dogs. In the late stage of the disease, it determines chronic neuropathic pain which leads to reduced quality-of-life in affected patients. To date it has not yet been identified a specific treatment, but it has been proved that nutraceutical and dietary supplements may play an important role in controlling inflammation and pain. The aim of this study was to evaluate, by the use of force plate gait analysis, the clinical efficacy of Boswellia and Curcuvet® combined with conventional nutraceutical therapy compared with conventional nutraceutical alone in dogs affected by osteoarthritis. MATERIALS AND

methodsTwenty client-owned dogs, over 12 months old and 20 kg of body-weight, with a confirmed diagnosis of Osteoarthritis, were included in this randomized, double-blinded study. The dogs were randomly divided into two groups: the first group (A) received a conventional nutraceutical (consisted in a preparation of glucosamine, chondroitin sulfate, fish-oil containing 80% of omega 3-fatty acid, vitamin C and E, saccharomyces Cerevisiae) with a combination of acid boswellic and Curcuvet®, while the second group (B) received a conventional nutraceutical. All the enrolled dogs underwent a washout period before starting the treatment with nutraceuticals products which were the only admitted treatment over the study period. A full orthopaedic and neurologic examination, and force plate gait analysis were performed before starting the treatment, at 45, 90, and 60 days post-treatment. Ground reaction forces were recorded and analyzed.

resultsTwenty dogs were enrolled in the study. In both groups there was an increasing values of ground reaction forces. These results might indicate that both nutraceutical products determined a better condition in terms of pain feeling but that effect is much more visible after 60 days from the end of the administration in treated group. DISCUSSION: In conclusion Curcuvet in combination with Boswellic acid could be considered a valid aid in a multimodal treatment for canine osteoarthritis.

Indexed as

AnimalsAscorbic AcidBody WeightBoswelliaChondroitin SulfatesDogsFatty Acids, Omega-6FemaleGlucosamineMaleOsteoarthritisPlant ExtractsTriterpenesVitamin EAscorbic Acidboswellic acidChondroitin SulfatesFatty Acids, Omega-6GlucosaminePlant ExtractsTriterpenesVitamin E

Identifiers

PMID34048452
PMCPMC8162585
OpenAlexW3165726771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.